A single center experience of intravenous immunoglobulin treatment in Covid-19.

Int Immunopharmacol · 2021 · PMC8200303 · PMID 34153671

Europe PMC DOI

hedged sentences

0.0870

closest p · 1.7× alpha

0.0870

boldest claim

The sentences

close to significancep = 0.087so close (0.05 < p ≤ 0.1)

Mortality was significantly lower in group 3 when compared to group 1 (64.7% vs 18.2%, p = 0.016) and close to significance when compared to group 2 (50% vs 18.2% p = 0.087).

also in 2,130 other papers

an increasing trendno p-value reported

An increasing trend in mortality rate was observed in patient groups 1 and 2, suggesting worse outcomes in presence of progressive disease refractory to other anti-inflammatory agents, Covid-19 related immunogenic complications and secondary infection.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.